Journal of Controlled Release : Official Journal of the Controlled Release Society
-
Publication Venue For
- A review of lipidation in the development of advanced protein and peptide therapeutics.. 295:1-12. 2019
- Chelation, formulation, encapsulation, retention, and in vivo biodistribution of hydrophobic nanoparticles labelled with 57Co-porphyrin: Oleylamine ensures stable chelation of cobalt in nanoparticles that accumulate in tumors.. 291:11-25. 2018
- Intra-articular clearance of labeled dextrans from naive and arthritic rat knee joints.. 283:76-83. 2018
- Accelerated wound healing by injectable star poly(ethylene glycol)-b-poly(propylene sulfide) scaffolds loaded with poorly water-soluble drugs.. 282:156-165. 2018
- Intranasal delivery of adjuvant-free peptide nanofibers elicits resident CD8+ T cell responses.. 282:120-130. 2018
- Fusion of fibroblast growth factor 21 to a thermally responsive biopolymer forms an injectable depot with sustained anti-diabetic action.. 277:154-164. 2018
- Encapsulation and controlled release of retinol from silicone particles for topical delivery.. 278:37-48. 2018
- Nanoparticle formulation improves doxorubicin efficacy by enhancing host antitumor immunity.. 269:364-373. 2018
- A quantitative study of the intracellular fate of pH-responsive doxorubicin-polypeptide nanoparticles.. 260:100-110. 2017
- Controlled release of biologics for the treatment of type 2 diabetes.. 240:151-164. 2016
- Injectable polypeptide micelles that form radiation crosslinked hydrogels in situ for intratumoral radiotherapy.. 228:58-66. 2016
- Intranasal mRNA nanoparticle vaccination induces prophylactic and therapeutic anti-tumor immunity.. 213:e66-e67. 2015
- Doxorubicin-conjugated polypeptide nanoparticles inhibit metastasis in two murine models of carcinoma.. 208:52-58. 2015
- Applications of elastin-like polypeptides in drug delivery. 190:314-330. 2014
- Applications of elastin-like polypeptides in drug delivery.. 190:314-330. 2014
- Hydrogel-nanoparticle composites for optically modulated cancer therapeutic delivery.. 178:63-68. 2014
- A depot-forming glucagon-like peptide-1 fusion protein reduces blood glucose for five days with a single injection.. 172:144-151. 2013
- A genetically engineered thermally responsive sustained release curcumin depot to treat neuroinflammation.. 171:38-47. 2013
- Doxorubicin-conjugated chimeric polypeptide nanoparticles that respond to mild hyperthermia.. 159:362-367. 2012
- In vivo tumor targeting by a NGR-decorated micelle of a recombinant diblock copolypeptide.. 155:144-151. 2011
- Hyaluronic acid and fibrin hydrogels with concentrated DNA/PEI polyplexes for local gene delivery.. 153:255-261. 2011
- Non-invasive monitoring of intra-tumor drug concentration and therapeutic response using optical spectroscopy.. 142:457-464. 2010
- Temperature-sensitive hydrogels with SiO2 -Au nanoshells for controlled drug delivery. 123:219-227. 2007
- Tumor accumulation, degradation and pharmacokinetics of elastin-like polypeptides in nude mice. 116:170-178. 2006
- Tumor accumulation, degradation and pharmacokinetics of elastin-like polypeptides in nude mice.. 116:170-178. 2006
- A thermally responsive biopolymer for intra-articular drug delivery.. 115:175-182. 2006
- A dual-ligand approach for enhancing targeting selectivity of therapeutic nanocarriers.. 114:277-287. 2006
- Tracking the in vivo fate of recombinant polypeptides by isotopic labeling.. 114:184-192. 2006
- Structural optimization of a "smart" doxorubicin-polypeptide conjugate for thermally targeted delivery to solid tumors.. 110:362-369. 2006
- The role of cavitation in acoustically activated drug delivery.. 107:253-261. 2005
- Controlled release of anti-inflammatory agent alpha-MSH from neural implants.. 106:309-318. 2005
- Cytosolic delivery of macromolecules 4. Head group-dependent membrane permeabilization by pH-sensitive detergents.. 106:146-153. 2005
- Folate targeting of drug carriers: a mathematical model.. 104:113-128. 2005
- Preparation of in vivo cleavable agglomerated liposomes suitable for modulated pulmonary drug delivery.. 103:159-175. 2005
- Covalent immobilization of RGDS on hydrogel surfaces to direct cell alignment and migration. 109:139-148. 2005
- Transdermal delivery of macromolecules by erbium:YAG laser.. 100:75-85. 2004
- Substrate-mediated DNA delivery: role of the cationic polymer structure and extent of modification.. 93:69-84. 2003
- Controlled targeting of liposomal doxorubicin via the folate receptor in vitro.. 92:49-67. 2003
- Evaluation of an elastin-like polypeptide-doxorubicin conjugate for cancer therapy.. 91:31-43. 2003
- Sustained release of plasmid DNA using lipid microtubules and agarose hydrogel.. 88:321-331. 2003
- Drug targeting using thermally responsive polymers and local hyperthermia.. 74:213-224. 2001
- Transdermal drug delivery enhanced and controlled by erbium:YAG laser: a comparative study of lipophilic and hydrophilic drugs.. 75:155-166. 2001
- Lipid-based microtubular drug delivery vehicles.. 71:141-152. 2001
- Lipid-coated microgels for the triggered release of doxorubicin.. 68:9-22. 2000
- Molecular engineering of proteins and polymers for targeting and intracellular delivery of therapeutics.. 65:203-220. 2000
- Factors influencing nonoxynol-9 permeation and bioactivity in cervical mucus.. 60:23-34. 1999
- Spectrophotometric analysis of molecular transport in gels.. 57:127-140. 1999
- Sustained release of exendin-4 from tannic acid/Fe (III) nanoparticles prolongs blood glycemic control in a mouse model of type II diabetes.. 301:119-128.
- A robust microparticle platform for a STING-targeted adjuvant that enhances both humoral and cellular immunity during vaccination. 2018
- Tracking the in vivo fate of recombinant polypeptides by isotopic labeling 2006